Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine.
In mammals DNA methylation occurs at position 5 of cytosine in a CpG context and regulates gene expression. It plays an important role in diseases and inhibitors of DNA methyltransferases (DNMTs)--the enzymes responsible for DNA methylation--are used in clinics for cancer therapy. The most potent inhibitors are 5-azacytidine and 5-azadeoxycytidine. Zebularine (1-(beta-D-ribofuranosyl)-2(1H)- pyrimidinone) is another cytidine analog described as a potent inhibitor that acts by forming a covalent complex with DNMT when incorporated into DNA. Here we bring additional experiments to explain its mechanism of action. First, we observe an increase in the DNA binding when zebularine is incorporated into the DNA, compared to deoxycytidine and 5-fluorodeoxycytidine, together with a strong decrease in the dissociation rate. Second, we show by denaturing gel analysis that the intermediate covalent complex between the enzyme and the DNA is reversible, differing thus from 5-fluorodeoxycytidine. Third, no methylation reaction occurs when zebularine is present in the DNA. We confirm that zebularine exerts its demethylation activity by stabilizing the binding of DNMTs to DNA, hindering the methylation and decreasing the dissociation, thereby trapping the enzyme and preventing turnover even at other sites.
Champion
Christine
C
MNHN CNRS UMR7196, Paris, France.
Guianvarc'h
Dominique
D
Sénamaud-Beaufort
Catherine
C
Jurkowska
Renata Z
RZ
Jeltsch
Albert
A
Ponger
Loïc
L
Arimondo
Paola B
PB
Guieysse-Peugeot
Anne-Laure
AL
D000818:Animals; D001374:Azacitidine / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology; D001483:Base Sequence; D003562:Cytidine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D004247:DNA / Q000235:genetics / Q000378:metabolism; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism*; D000077209:Decitabine; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D008745:Methylation / Q000187:drug effects; D051379:Mice
D004791:Enzyme Inhibitors; D003562:Cytidine; D000077209:Decitabine; C009131:pyrimidin-2-one beta-ribofuranoside; D004247:DNA; D004248:DNA (Cytosine-5-)-Methyltransferases; D001374:Azacitidine
J Mol Biol. 2003 Jun 13;329(4):675-84
12787669
Cancer Chemother Pharmacol. 2009 Feb;63(3):411-6
18398609
Oncogene. 2002 Aug 12;21(35):5483-95
12154409
Biochem J. 1995 Apr 1;307 ( Pt 1):87-92
7536414
J Mol Biol. 1996 Sep 6;261(5):634-45
8800212
Exp Hematol. 2007 Feb;35(2):263-73
17258075
DNA Repair (Amst). 2004 Feb 3;3(2):155-61
14706349
Cell. 1995 Jul 14;82(1):143-53
7606780
Leukemia. 2009 Jun;23(6):1019-28
19194470
Cancer Prev Res (Phila). 2008 Sep;1(4):233-40
19138966
J Mol Biol. 1999 Feb 19;286(2):389-401
9973559
Nature. 2004 May 27;429(6990):457-63
15164071
J Pharm Sci. 1981 Nov;70(11):1228-32
6170748
J Mol Biol. 2002 Aug 23;321(4):591-9
12206775
Oncogene. 2002 Aug 12;21(35):5400-13
12154403
Clin Cancer Res. 2005 Jun 15;11(12):4571-9
15958643
Nat Rev Drug Discov. 2005 Apr;4(4):275-6
15861567
Cancer Chemother Pharmacol. 2009 Jul;64(2):223-32
18830594
J Biol Chem. 1982 Feb 25;257(4):2041-8
6173384
Nat Rev Drug Discov. 2006 Nov;5(11):891-2
17117522
Cancer Chemother Pharmacol. 1992;30(1):7-11
1375134
J Biol Chem. 2002 Jun 7;277(23):20409-14
11919202
Mol Cancer Ther. 2005 Oct;4(10):1505-14
16227399
J Pharm Sci. 1975 Jul;64(7):1148-57
50433
Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R65-76
15809275
Biochim Biophys Acta. 2009 Nov;1794(11):1654-62
19654054
Ann N Y Acad Sci. 2003 Dec;1002:154-64
14751833
Anal Chem. 2005 Jan 15;77(2):504-10
15649046
Proc Natl Acad Sci U S A. 1984 Nov;81(22):6993-7
6209710
Nucleic Acids Res. 1992 Jun 25;20(12):3241-8
1620620
Epigenetics. 2006 Apr-Jun;1(2):63-6
17965604
J Biol Chem. 2002 Apr 5;277(14):11735-45
11821381
J Mol Biol. 1982 Dec 15;162(3):679-92
6187927
J Med Chem. 1986 Aug;29(8):1374-80
3735306
Biochem J. 1993 Apr 15;291 ( Pt 2):493-504
8484730
Anal Biochem. 2003 Oct 1;321(1):50-64
12963055
J Am Chem Soc. 2008 Dec 31;130(52):17634-5
19108695
Nat Rev Drug Discov. 2006 Jan;5(1):37-50
16485345
Cell. 1985 Mar;40(3):485-6
2578884
Mol Cell Biol. 2003 Apr;23(8):2709-19
12665573
Cell Mol Life Sci. 2004 Oct;61(19-20):2571-87
15526163
Cell. 1980 May;20(1):85-93
6156004
Cancer Res. 2006 Mar 1;66(5):2794-800
16510601
Biochemistry. 1988 Jul 12;27(14):5204-10
3167042
Ann N Y Acad Sci. 2005 Nov;1058:246-54
16394141
Mol Cancer Ther. 2006 Feb;5(2):467-75
16505122
Curr Top Microbiol Immunol. 2006;301:203-25
16570849
PLoS Genet. 2009 Mar;5(3):e1000438
19325872
J Med Chem. 1991 Nov;34(11):3280-4
1956046
Biochem Soc Trans. 2004 Dec;32(Pt 6):910-2
15506921
Nucleic Acids Res. 1993 May 25;21(10):2459-64
8506140
J Natl Cancer Inst. 2003 Mar 5;95(5):399-409
12618505
Carcinogenesis. 2000 Mar;21(3):461-7
10688866
Mol Cell Biol. 2004 Feb;24(3):1270-8
14729971
Annu Rev Biochem. 1983;52:93-124
6311083
Biochem Pharmacol. 2009 Sep 15;78(6):633-41
19467223